Stock data
Teva Pharmaceutical Industries Limited (TEVA)
Teva Pharmaceutical Industries Limited (TEVA) reported revenue of US$17.26B and net income of US$1.41B for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$17.26B | US$8.94B | US$2.16B | US$1.41B | — |
| 2024 | US$16.54B | US$8.06B | -US$303.00M | -US$1.64B | — |
| 2023 | US$15.85B | US$7.64B | US$433.00M | -US$559.00M | — |
| 2022 | US$14.93B | US$6.97B | -US$2.20B | -US$2.45B | — |
| 2021 | US$15.88B | US$7.59B | US$1.72B | US$417.00M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$4.14B | -US$576.00M | — |
| 2026-03-31 | US$3.98B | US$369.00M | — |
| 2025-12-31 | US$4.71B | US$481.00M | — |
| 2025-09-30 | US$4.48B | US$433.00M | — |
| 2025-06-30 | US$4.18B | US$282.00M | — |
| 2025-03-31 | US$3.89B | US$214.00M | — |
| 2024-12-31 | US$4.23B | -US$217.00M | — |
| 2024-09-30 | US$4.33B | -US$437.00M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.